APA (7th ed.) Citation

Rossi, B., Blanche, P., Roussel‐Robert, V., Berezné, A., Combe, S., Coppo, P., . . . Groh, M. (2016). Rituximab as first-line therapy for acquired haemophilia A: A single-centre 10-year experience. Haemophilia, 22(4), e338. https://doi.org/10.1111/hae.12973

Chicago Style (17th ed.) Citation

Rossi, B., et al. "Rituximab as First-line Therapy for Acquired Haemophilia A: A Single-centre 10-year Experience." Haemophilia 22, no. 4 (2016): e338. https://doi.org/10.1111/hae.12973.

MLA (9th ed.) Citation

Rossi, B., et al. "Rituximab as First-line Therapy for Acquired Haemophilia A: A Single-centre 10-year Experience." Haemophilia, vol. 22, no. 4, 2016, p. e338, https://doi.org/10.1111/hae.12973.